Is the price fair?
What ASTH's price assumes
Astrana Health, Inc. trades at 61.5× earnings against 19.6× for the median Medical Care Facilities name, more expensive than its own group.
61.5
Trailing P/E · Medical Care Facilities median 19.6 · 3.14× the median: the market pays up for this one
- Price / sales
- 0.34
Price / sales · as of 2026-Q1
- Free cash flow yield
- 7.2%
Free cash flow yield · Medical Care Facilities median 7.1%
- Growth the price implies
- +0.83%
Growth the price implies · The price pays for +0.83% free cash flow growth a year for a decade; the business has delivered +42% a year over the last three.
Details›
- Price / book2026-Q1
- 1.50
- EV / EBIToperating margin 2.5%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 0.48
- Healthcare median P/E362 names
- 29.9
- Medical Care Facilities median P/E29 names
- 19.6
- Free cash flow, trailing twelve months
- $155M
- Market capitalisation
- $2.16B
- 3-year revenue growth
- +43%
- 3-year free cash flow growth
- +42%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $19.49 |
| Its own P/E history, median | $22.96 |
| Its own P/E history, upper quartile | $33.28 |
| 52-week range | $18.16 – $49.01 |
| Today | $38.12 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.